跳至主要内容
临床试验/ISRCTN10550694
ISRCTN10550694已完成未知

A programme of work to develop and evaluate an intervention to promote activity and independence for people with early dementia and mild cognitive impairment

ottingham University Hospitals Trust0 个研究点目标入组 60 人开始时间: 2016年8月31日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
60

研究概览

简要总结

2018 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/29468084 protocol 2018 Other publications in https://www.ncbi.nlm.nih.gov/pubmed/29436253 development of the intervention 2019 Results article in https://www.ncbi.nlm.nih.gov/pubmed/31842828 results (added 18/12/2019) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35677674/ Social return on investment results (added 10/06/2022)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1.1. Health care staff with professional knowledge and expertise on falls, dementia, or related health conditions
  • 1.2. The PPI focus group will be recruited from members of a established dementia-specialist PPI group
  • 1.3. Patient and carer focus group, will be a group of people with mild dementia, meeting the inclusion criteria for the feasibility trial (recruited via Alzheimer Society)
  • 2. WP2: Uptake and adherence focus group. A group of people with mild dementia, meeting the inclusion criteria for the feasibility trial, and their family carers (recruited via Alzheimer Society)
  • 3. WP3 feasibility trial:
  • 3.1 Age 65 or over (no maximum)
  • 3.2. A diagnosis of dementia or MCI (of any subtype)
  • 3.3. Able to walk without human help
  • 3.4. Able to communicate in English, with a translator if necessary
  • 3.5. Able to see, hear and have dexterity sufficiently to perform neuropsychological tests
  • 3.6. Capacity to give consent to participate, and agreeing to do so
  • 3.7. Montreal Cognitive Assessment (MoCA) 15-25 or Mini-mental state examination (MMSE) 18-26 or Addenbrooke's Cognitive Examination (ACE-III) 50-83
  • 4. Carer participants will be spouses, family members or others in a caring relationship who see the patient participant for at least an hour most weeks, are willing to take part and can communicate in English, with a translator if necessary
  • 5. WP4: Patient participants will be drawn from those taking part in WP3 (supplemented by those in the main trial, WP5 if needed). Semi-structured interviews will be conducted with about 10 participants in each active-treatment arm in the feasibility study (moderate- and high- intensity supervision). Carers will be interviewed separately, if they are willing

排除标准

  • 1. WP 1-2: There will be no specific exclusion criteria, but people recruited are likely to be those who would otherwise have been appropriate for the feasibility trial
  • 2.1. Co-morbidity preventing participation (e.g. severe breathlessness, pain, psychosis, Parkinson’s or other severe neurological disease)
  • 2.2. Life expectancy of less than 1 year
  • 2.3. Likely to be unable to undertake the intervention regularly (e.g. planned elective surgery, planning to move away or commitments elsewhere)
  • 3. WP4 participants will be drawn from those taking part in WP3, exclusion criteria will be the same

研究者

发起方
ottingham University Hospitals Trust

相似试验